Fortress Biotech Inc (FBIO) - Financial and Strategic SWOT Analysis Review
Fortress Biotech Inc (FBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Fortress Biotech Inc (Fortress Biotech), formerly Coronado Biosciences Inc, identifies, acquires, develops, and commercializes marketed pharmaceuticals and development-stage pharmaceutical product candidates. The company offers business, scientific, regulatory and legal support for advancing the products or product candidates of its partner firms. It is a marketing partner for various branded drugs indicated for the treatment of radiation dermatitis, severe acne, athlete’s foot, inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and other skin infections. It also holds intellectual property rights and licenses for product candidates of Aevitas Therapeutics, Caelum Biosciences, Cellvation, Checkpoint Therapeutics, Avenue Therapeutics, Helocyte, Journey Medical Corp, Mustang Bio, Cyprium Therapeutics, and Tamid Bio. Fortress Biotech is headquartered in New York, the US.
Fortress Biotech Inc Key Recent Developments
Nov 15,2021: Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights
Nov 04,2021: Checkpoint Therapeutics Reports Third Quarter 2021 Financial Results
Oct 25,2021: Avenue Therapeutics receives interim response to its formal dispute resolution request from U.S. Food and drug Administration office of new drugs
Oct 18,2021: Fortress Biotech to Participate in Dawson James Securities’ 6th Annual Small Cap Growth Conference
Sep 28,2021: Fortress Biotech to participate in the Benzinga Healthcare Small Cap conference
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Fortress Biotech Inc (Fortress Biotech), formerly Coronado Biosciences Inc, identifies, acquires, develops, and commercializes marketed pharmaceuticals and development-stage pharmaceutical product candidates. The company offers business, scientific, regulatory and legal support for advancing the products or product candidates of its partner firms. It is a marketing partner for various branded drugs indicated for the treatment of radiation dermatitis, severe acne, athlete’s foot, inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and other skin infections. It also holds intellectual property rights and licenses for product candidates of Aevitas Therapeutics, Caelum Biosciences, Cellvation, Checkpoint Therapeutics, Avenue Therapeutics, Helocyte, Journey Medical Corp, Mustang Bio, Cyprium Therapeutics, and Tamid Bio. Fortress Biotech is headquartered in New York, the US.
Fortress Biotech Inc Key Recent Developments
Nov 15,2021: Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights
Nov 04,2021: Checkpoint Therapeutics Reports Third Quarter 2021 Financial Results
Oct 25,2021: Avenue Therapeutics receives interim response to its formal dispute resolution request from U.S. Food and drug Administration office of new drugs
Oct 18,2021: Fortress Biotech to Participate in Dawson James Securities’ 6th Annual Small Cap Growth Conference
Sep 28,2021: Fortress Biotech to participate in the Benzinga Healthcare Small Cap conference
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Fortress Biotech Inc - Key Facts
Fortress Biotech Inc - Key Employees
Fortress Biotech Inc - Key Employee Biographies
Fortress Biotech Inc - Major Products and Services
Fortress Biotech Inc - History
Fortress Biotech Inc - Company Statement
Fortress Biotech Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Fortress Biotech Inc - Business Description
Business Segment: Dermatology Product Sales
Overview
Performance
Business Segment: Pharmaceutical and Biotechnology Product Development
Overview
Performance
R&D Overview
Fortress Biotech Inc - SWOT Analysis
SWOT Analysis - Overview
Fortress Biotech Inc - Strengths
Fortress Biotech Inc - Weaknesses
Fortress Biotech Inc - Opportunities
Fortress Biotech Inc - Threats
Fortress Biotech Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fortress Biotech Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Nov 15, 2021: Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights
Nov 04, 2021: Checkpoint Therapeutics Reports Third Quarter 2021 Financial Results
Oct 25, 2021: Avenue Therapeutics receives interim response to its formal dispute resolution request from U.S. Food and drug Administration office of new drugs
Oct 18, 2021: Fortress Biotech to Participate in Dawson James Securities’ 6th Annual Small Cap Growth Conference
Sep 28, 2021: Fortress Biotech to participate in the Benzinga Healthcare Small Cap conference
Aug 16, 2021: Mustang Bio Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights
Aug 16, 2021: Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights
May 16, 2021: Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
May 14, 2021: Mustang Bio Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
Apr 07, 2021: Fortress Biotech to Participate in the 20th Annual Needham Virtual Healthcare Conference
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Fortress Biotech Inc - Key Facts
Fortress Biotech Inc - Key Employees
Fortress Biotech Inc - Key Employee Biographies
Fortress Biotech Inc - Major Products and Services
Fortress Biotech Inc - History
Fortress Biotech Inc - Company Statement
Fortress Biotech Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Fortress Biotech Inc - Business Description
Business Segment: Dermatology Product Sales
Overview
Performance
Business Segment: Pharmaceutical and Biotechnology Product Development
Overview
Performance
R&D Overview
Fortress Biotech Inc - SWOT Analysis
SWOT Analysis - Overview
Fortress Biotech Inc - Strengths
Fortress Biotech Inc - Weaknesses
Fortress Biotech Inc - Opportunities
Fortress Biotech Inc - Threats
Fortress Biotech Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fortress Biotech Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Nov 15, 2021: Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights
Nov 04, 2021: Checkpoint Therapeutics Reports Third Quarter 2021 Financial Results
Oct 25, 2021: Avenue Therapeutics receives interim response to its formal dispute resolution request from U.S. Food and drug Administration office of new drugs
Oct 18, 2021: Fortress Biotech to Participate in Dawson James Securities’ 6th Annual Small Cap Growth Conference
Sep 28, 2021: Fortress Biotech to participate in the Benzinga Healthcare Small Cap conference
Aug 16, 2021: Mustang Bio Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights
Aug 16, 2021: Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights
May 16, 2021: Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
May 14, 2021: Mustang Bio Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
Apr 07, 2021: Fortress Biotech to Participate in the 20th Annual Needham Virtual Healthcare Conference
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Fortress Biotech Inc, Key Facts
Fortress Biotech Inc, Key Employees
Fortress Biotech Inc, Key Employee Biographies
Fortress Biotech Inc, Major Products and Services
Fortress Biotech Inc, History
Fortress Biotech Inc, Other Locations
Fortress Biotech Inc, Subsidiaries
Fortress Biotech Inc, Key Competitors
Fortress Biotech Inc, Ratios based on current share price
Fortress Biotech Inc, Annual Ratios
Fortress Biotech Inc, Annual Ratios (Cont...1)
Fortress Biotech Inc, Annual Ratios (Cont...2)
Fortress Biotech Inc, Interim Ratios
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fortress Biotech Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Fortress Biotech Inc, Key Facts
Fortress Biotech Inc, Key Employees
Fortress Biotech Inc, Key Employee Biographies
Fortress Biotech Inc, Major Products and Services
Fortress Biotech Inc, History
Fortress Biotech Inc, Other Locations
Fortress Biotech Inc, Subsidiaries
Fortress Biotech Inc, Key Competitors
Fortress Biotech Inc, Ratios based on current share price
Fortress Biotech Inc, Annual Ratios
Fortress Biotech Inc, Annual Ratios (Cont...1)
Fortress Biotech Inc, Annual Ratios (Cont...2)
Fortress Biotech Inc, Interim Ratios
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Fortress Biotech Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Fortress Biotech Inc, Performance Chart (2016 - 2020)
Fortress Biotech Inc, Ratio Charts
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Fortress Biotech Inc, Performance Chart (2016 - 2020)
Fortress Biotech Inc, Ratio Charts
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021